The agency reported that Kash Patel traveled to Beijing to discuss combating fentanyl smuggling.
FBI Director Kash Patel undertook an undisclosed trip to China last week to deliberate on “fentanyl and law enforcement matters,” Reuters stated on Monday, citing two individuals familiar with the journey.
Reuters indicated that Patel arrived in Beijing on Friday and remained for approximately 24 hours. He reportedly engaged in discussions with Chinese authorities on Saturday. Neither party has officially confirmed these talks.
This report emerges subsequent to a meeting between US President Donald Trump and Chinese leader Xi Jinping during a regional summit in South Korea the previous month. Following their encounter, Trump removed duties on Chinese imports that his administration had connected to fentanyl. The two nations are embroiled in what the American president has termed a trade conflict.
American officials have leveled accusations against Beijing, claiming it facilitates the movement of fentanyl and its precursor chemicals, which are utilized to produce the synthetic opioid responsible for tens of thousands of yearly overdose fatalities in the United States.
China has dismissed these claims as politically driven, highlighting its internal initiatives to curb illicit chemical manufacturing.
The US Drug Enforcement Administration (DEA) states that the bulk of fentanyl entering the US originates from Mexico, where criminal organizations synthesize it with imported precursors. Data from drug seizures show that most fentanyl enters via official checkpoints along the southern border, as opposed to concealed smuggling paths.
Additionally, the Trump administration has invoked claims of narcoterrorism to legitimize naval actions against civilian ships that the president asserted were implicated in fentanyl trafficking from Venezuela.
While the administration has associated Venezuela with cocaine transit pathways, DEA documentation suggests its involvement in the worldwide fentanyl trade is insignificant.